Proceedings of the 52nd Hawaii International Conference on System Sciences | 2019

An Innovation Platform for Diffusing Public Health Practices across a Global
Network
Alexander Plum
Henry Ford Health System
aplum2@hfhs.org

Mohan Tanniru
Henry Ford Health System
mtannir1@hfhs.org

Abstract
Hospitals and health systems in high-income
countries (HIC) develop the capacities of peer
healthcare organizations around the world by diffusing
clinical, quality, and public health improvement
practices in lower and middle-income countries
(LMIC). In turn, these HIC healthcare institutions are
exposed to innovative approaches developed and used
by global communities to advance care despite
resource constraints in the LMIC contexts. Attention
has been growing in recent years to the potential these
innovations can have to improve care delivery, lower
costs, and drive quality within resource constrained
communities in HIC. Often referred to as ‘reverse
innovations,’ the identification, adaptation, and
diffusion of these practices face challenges in uptake
related to limited evidence, perceptions of poor quality
or irrelevance, and a complicated regulatory and
policy environment. This paper suggests the
development of a knowledge platform to support
diffusion of innovative health practices along a global
community continuum and illustrates its potential use.

Jiban Khuntia
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where there are logistical challenges, how to educate a
diverse array of caregivers in professional and lay
contexts, how to build the capacity of medical
researchers, and how to leverage social support
structures to overcome stigma about medical
conditions are only a handful of examples that
demonstrate innovation flow from high-income
countries (HIC) to low- and middle-income countries
(LMIC), a process we refer to as ‘high-low
innovation.’ Figure 1 illustrates the role of an HIC
healthcare institution in moving innovations in this
direction using a number of diffusion strategies.

Figure 1: Innovation and Diffusion Strategies

1. Introduction
Hospitals and health care systems in the United
States are increasingly becoming engaged with their
peer institutions around the world. As a result, learning
is taking place between organizations that results in
new opportunities, organizational growth, increased
job satisfaction, better market position, improved brand
recognition, and, most importantly, better health care
provision for patients and communities alike.
At the core of these hospital and health system
partnerships are opportunities for reciprocal exchange
of ideas, approaches, and expertise. Often referred to as
international health partnerships, examples in the
literature include collaborative trainings, research
activities, capacity development, and service delivery
[1]. Determining how to move medicine to places
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The flow of innovations in the opposite direction
is still nascent in healthcare. In this direction, HIC
healthcare institutions discover certain medical and
non-medical innovations that are used in LMIC to
address the unique healthcare needs of communities
with significant resource constraints. Examples of
these innovations include community healthcare
workforces to arrest HIV rates, support pregnant
mothers, and improve mental health outcomes [2, 3];
mobile applications to facilitate cash transfers to help
pay for medical care and better collect and analyze data
[4, 5]; and devices and products that can quickly
identify disease and support treatment [6, 7].
Indigenously developed in LMIC contexts to overcome
specific community challenges and resource
constraints, these innovations are potentially applicable
to other regions with similar scarcity characteristics,
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including cities and regions in HIC such as the United
States. Water contamination issues in Flint, Michigan
over the past several years provides an example for the
potential application of water filters for cleaner water
in a similar resource-limited, HIC setting. These ‘lowhigh innovations’ are often referred as ‘reverse
innovations’ and are shown in the lower part of the
left-hand block of Figure 1.
The goal of this paper is to develop effective
mechanisms to explore the viability and facilitate the
diffusion of innovations that flow in both ‘high-low’
and ‘low-high’ directions, specifically from the
perspective of an HIC healthcare institution. Diffusion,
at its core, is a social phenomenon that is informed by
the interconnectedness of actors involved in an
innovation’s design, testing, communication, and,
eventually, uptake [8]. Because it is a social process,
innovation adoption is informed by the social and
structural positions in which innovation disseminators
and potential adopters respectively find themselves [9,
10]. Thus, perceptions of credibility and effectiveness,
along with trust and deference matter as much on the
part of innovators and adopters as on the innovations
themselves. Social positions and attendant hierarchies
of innovators and adopters alike inform how well
innovations can be diffused.
Nowhere is this more apparent than in the
disparity in innovation diffusion between ‘high-low’
and ‘low-high’ contexts. While the high-low path of
innovation has been a widely accepted expectation and
norm (thus, without significant barriers), challenges to
‘low-high’ diffusion have included regulation hurdles,
legal barriers, and stigmas based on negative
perceptions regarding source location, adherence to
quality standards, and relevance or applicability in HIC
[11, 12]. In fact, even the name used most often in the
literature to refer to ‘low-high’ innovations (i.e.
‘reverse innovation’) implies a negative connotation
that many, including these authors, find problematic
[12].
Indeed, this diffusion disparity is reflected through
the lowest-shelf placement of use-and-throw shaving
razors and the relegation of sachet-shampoo in big-box
stores to the travel-size and sample bins. In comparison
to pricey and branded products, these ‘good enough’
products are considered ‘cheap’ and ‘lackluster.’ Such
perceptions and connotations lead to feelings of
disenchantment and rejection for low-high innovations.
The research question, therefore, is especially
concerned with developing an approach that addresses
challenges associated with diffusion of innovations
within low-high contexts, while keeping intact the
underlying integrity and value of the innovations
across the adoption process and engaged societal
contexts. The paper is organized as follows:

Section Two discusses diffusion theory and
highlights a specific approach called ‘design for
diffusion.’ Sections Three and Four describe a case
study to demonstrate how this approach has facilitated
the successful diffusion of two innovations within a
low-high context. Based on this experience, Section
Five proposes a generalizable platform to support the
bidirectional flow of innovations for diffusion in both
high-low and low-high contexts. Section Six provides
some concluding comments and directions for future
research.

2. Prior research
Diffusion theory has been well-documented in the
literature. Beginning with Everett Rogers’ seminal
work in 1962, researchers have applied and revised his
tenets that inform how and whether an innovation will
diffuse across domains and fields of interest [13].
Rogers and scholars that followed him cite common
innovation attributes that either facilitate or prevent
diffusion from occurring. These include an
innovation’s compatibility to existing approaches,
costs of success or failure, simplicity to adopt,
potential effectiveness, whether effectiveness has been
or can be observed, and the ease with which
innovations can be informally trialed [8]. The
dynamics of innovation diffusion in the healthcare
industry are complex. New medical and information
technologies often follow a slow pace of adoption in
healthcare, and the speed at which diffusion occurs is
also slow. The number of stakeholders in healthcare
potentially affected by a technology adoption decision
varies. For example, a clinician has to consider
reimbursement, policy, and organizational models
beyond the impact of a technology on patient and
practice of care. Rogers’ change agent factor, i.e., an
individual who influences clients’ innovation decisions
in a direction deemed desirable by an agency, is
predominant in the healthcare sector, where almost
60,000 pharmaceutical sales representatives, as change
agents, influence innovation decisions. Thus, arguably,
within healthcare, it is pointed out that diffusion often
occurs because of intentional dissemination activities,
not the strength of evidence alone [8].
For resource-constrained populations seeking high
quality health outcomes, there are additional challenges
for innovation diffusion and uptake besides intention to
adopt or strength of evidence. In these environments,
individuals often cannot afford to pay high sums to
achieve the desired outcomes. In settings where
infrastructure and onerous regulation are either
underdeveloped or absent, the environment is prime for
creating product and technology innovations to
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facilitate training, education, quality healthcare
delivery, data collection, logistics management, and
workforce deployment. In these settings, innovations
must apply to broad populations for economies of scale
to achieve profitability, and the chosen diffusion
models must help address a challenging environment
or organizational context to nurture a creative,
sustainable solution to achieve health and wellness.
Understanding the contexts within which these
scarcity-informed innovations are developed is a
necessary precursor to describing and eventually
winning support for diffusion. The term reverse
innovation (RI) was coined to describe the flow of
innovative ideas from lower to higher income settings
[14]. As applied to healthcare, DePasse and Lee define
reverse innovation as “learning from and investing in
poorer settings as one way to tackle problems in
wealthier settings that require out-of-the-box solutions”
[15]. (Note: when the authors refer to ‘out-of-the-box’
they mean it in the sense of approaches that break the
mold and are new and innovative, not in the sense of a
pre-packaged, boxed ideas.) The secret to a reverse
innovation paradigm shift is to look for “value for
many” instead of “value for money” [16]. Rising
healthcare costs, insufficient insurance coverage,
inefficient public transportation, health illiteracy, and a
lack of trust in the health system are only a few of the
many factors that require a new paradigm for
healthcare innovations in the US and other HICs.
The literature on innovation diffusion theory is
overwhelmingly source agnostic, which complicates
the study of low-high innovation diffusion. Dearing
and colleagues offer one theoretical platform that may
be a useful starting point for exploring and explaining
the differences in how to diffuse innovations in both
‘high-low’ and ‘low-high’ directions: designing for
diffusion [8]. “Designing for diffusion is the taking of
strategic steps early in the process of creating and
refining an evidence-based intervention to increase its
chances of being noticed, positively perceived,
accessed, and tried and then adopted, implemented,
and sustained in practice” [8]. Using Dearing et. al.’s
designing for diffusion approach, the authors aim to
explore the research question by examining a case
study of an HIC healthcare institution that has
successfully facilitated bidirectional global innovation
flow.

3. Research methodology
Henry Ford Health System (HFHS), headquartered
in Detroit, Michigan, is a leading US healthcare
provider, comprised of hospitals, medical centers, a
health plan, and one of the nation's largest group

practices, the Henry Ford Medical Group. The Henry
Ford Global
Health
Initiative
(GHI) works
with healthcare partners in LMIC around the world to
co-develop medical capacity through training, research,
and exchange activities. Over time, as its program
relationships deepen, GHI learns about the innovative
solutions its partners and local communities use
to deliver healthcare services, deploy new workforces,
sustainably finance
care,
and
share
and
analyze information. Especially promising innovations
are identified and vetted for future adaptation and pilot
in Detroit, to improve the health of underserved
populations at home. This reciprocal innovation flow
of high-low capacity development and low-high
‘reverse innovation’ defines GHI's approach to
achieving equitable global health development and
serves as an enduring model of transformative
partnerships in healthcare.
We follow the case study methodology to illustrate
how the design for diffusion approach can help
structure the activities of GHI over the last few years.
Creswell et. al. [17] define the case study method as “a
qualitative approach in which the investigator explores
a bounded system (a case)… over time through
detailed, in-depth data collection involving multiple
sources of information (e.g., observations, interviews,
audiovisual material, and documents and reports) and
reports a case description and case-based themes” [17].
Over the course of 18 months, the authors
systematically categorized and refined the types of
‘high-low’ and ‘low-high’ innovations being shared.
Interviews were conducted with leaders at the HIC
institution, their respective LMIC partner institution
stakeholders and innovators, global thought leaders in
the nascent field of ‘reverse’ innovation, and quality
improvement advisers from leading healthcare
institutions in the US.
Table 1 describes the interviews, timeline, and
themes explored. In-depth notes from interviews were
taken and shared among the authors, who spent three
months surfacing themes, reconciling interpretations,
and drawing conclusions. Extant evaluation data of the
case study institution’s programs were reviewed and
analyzed to build the case description and surface
themes. Using the principles of grounded theory and
thematic analysis, the authors developed various
diffusion methods that evolved in their practice, and
this is discussed next.
Table 1: Representative Summary of Field Level
Interactions and Sources
Interviewees

Total hours spent in every Interview Themes
year for direct interview &
unstructured interactions
2014 2015 2016 2017 2018
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Chief Executive
Officer

3

CEO of Medical
Group

2

President of
Healthcare
Operations
Chief Innovation
Officer
Chief Wellness &
Diversity Officer
SVP, Population
Health
Clinical staff, nurse
managers
Patients &
consumers (n=40)
Community-based
organizations
(n=12)

2

2

2

3

3

3

3

3

2

6

4

8

7

2

8

Broad vision, strategy, and leadership
contexts; overarching opportunity for
global health leadership
Role of medical training and research
exchange to inform global health
leadership
Value proposition and alignment with
service lines to maximize return on
investment.
Role of technology and digital
innovations to support business case
Underserved communities; opportunities
for local impact, engagement, and a
focus on equity
Value-based and risk-based models to
structure and facilitate tests of change
Workflows, opportunities to achieve
efficiency, scope of practice concerns,
barriers, passion & satisfaction
Social determinants of health; local
context; barriers to accessing healthcare

8

8

6

8

10

10

10

10

10

10

6

10

12

10 Network & collaboration opportunities;
efforts to achieve complementarity in
service provision

Dearing et al’s design of diffusion process has four
phases [8]. The first, agenda-setting and assessing
readiness, begins before GHI engages its partners. For
‘high-low’ innovations, these are long-time and newly
identified partners in the ministry of health,
universities, health systems, and non-governmental
organizations (NGO) in LMIC. For ‘low-high’
innovations, these are internal health system
department leaders and clinicians, as well as local and
regional community partners. A year-long strategy
alignment process within HFHS led GHI to identify
five priority health topics with relevance to the health
system, to Detroit, and to the entire world. After
conducting structured in-depth interviews and focus
group conversations with patients, health system
leadership, and community representatives, and a
serious review of the literature, five priority topics
emerged: infant and maternal health, mental health,
metabolic health, sexual and reproductive health, and
stewardship of antibiotics. Only after categorizing its
strengths and expertise, and contextualizing these with
an acute awareness of its weaknesses, did GHI
approach its partners to learn their needs and receive
direction in how best to co-develop capacity and/or
import innovative solutions.
The second design for diffusion step is
dissemination and distribution. Using inductive
methods, GHI categorized the public health practices it
has used globally into six types of innovations, in
alignment with WHO’s building blocks of health
systems [18]: Healthcare service delivery innovations
to train medical institutions and local communities in
improvement of preventive and secondary medical care
delivery; workforce innovations, such as deploying
alternative workforces and/or training clinicians with
research skills to better collect, analyze, and diffuse
data and care practices; health information innovations,
which include the technology and data collection and

analysis applications to track and monitor health
outcomes; product innovations, which include the
vaccines, devices, and technologies used to facilitate
healthcare delivery and improvement; health financing
innovations that ensure sustainable health care delivery
through payment and reimbursement mechanisms; and
policy innovations, including rules, regulations,
policies, and standard operating procedures to improve
quality and efficiency of care. These six innovation
types represent a starting point from which GHI’s
partners can identify opportunities for innovation flow
to occur. Table 2 includes examples of communityexpressed goals (i.e. phase one: agenda setting) and the
relevant types of innovations selected for pilot projects
for diffusion (i.e. phase two: dissemination and
distribution).
Table 2. Examples of Paired Community Needs to
Innovation Types
Community Goal
Reduce overall time to train
medical specialists

Innovation Model
Process innovation: Introduce
specialist surgical ‘boot camp’ training
model
Improve research skills and Practice innovation: Jointly created
increase publications of early- mixed-methods research design &
and mid-stage medical staff training in-service short-course for
hospital staff
Maintain strict adherence to Policy innovation: Public advocacy
existing laws and prevent
campaign and engagement with senior
public smoking/tobacco use management to obtain support

The examples listed in Table 2 must be further
contextualized and refined by the characteristics of the
stakeholders whose engagement and acceptance will
define their diffusion. Such contextualization can be
based on diffusion strategies discussed earlier [12] (e.g.
evidence, trialability, simplicity, etc.), as well as
several other factors, such as adopter behavior,
innovation type, and relative advantage. Consideration
of these factors constitutes Dearing et al’s third phase,
which consists of engaging and winning over
influential stakeholders, gatekeepers, and community
representatives “whose trustworthiness and expertise
serve as social confirmation” that an innovation can be
successfully adopted [8]. As noted earlier, diffusion is
a social process, which means that the beliefs,
perceptions, and prejudices of adopters and innovators
alike converge to inform whether or not innovations
will even be selected for pilot and/or adaptation, let
alone fully diffused. This seldom prevents GHI’s
‘high-low’ innovation diffusion from occurring
successfully, but it has been a continual barrier to
successful ‘low-high’ innovation flow.
Only by convincing decision-makers and key
influencers of these innovations’ merits can GHI move
on to Dearing et al’s fourth and final phase of diffusion
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design, which is implementation into practice settings.
GHI has undertaken two such implementations over
the last two years - providing access to mental health
care and supporting access to care for homeless, young
LGBTQ individuals, and these will be discussed in the
next section.

4. Results
4.1 Mental Health Prevention
Providing access to mental healthcare to
populations in Detroit is challenging because many
patients lack transportation, do not have a single point
of contact with behavioral health or psychiatry
services, mistrust the health system, and are under- or
uninsured. Poor reimbursement levels and high
appointment cancellation rates also lead to waiting lists
that last several months, which can deter patients and
reinforce the high price of mental healthcare.
One of GHI’s long-term partners in a South Asian
LMIC identified an approach it used to construct
healthcare infrastructure in a sparsely populated,
rugged, mountainous setting. Their setting required
innovative approaches to maximize reach (i.e.
decentralize the workforce), while minimizing costs
(i.e. centralize capital and infrastructure). A service
delivery innovation called ‘hub and spoke’ guided the
establishment of health outposts in informal settings
like temples, schools, and municipal offices, which all
became spokes that were connected back to a central
‘hub’ hospital. A workforce innovation was developed,
whereby community health workers (CHWs) were
trained and equipped at the hub and then returned to
their villages to staff the spokes. Given that they were
usually the first and only point of contact for remote
villagers, CHWs helped improve chronic disease
management, contraceptive use prevalence, and
institutional births. Feedback from the CHWs revealed
a need for training in mental health first aid to address
contextual drivers of illness and disease [19].
GHI adapted the hub and spoke model for use in
Detroit to improve mental health treatment rates among
low-income adult patients of HFHS. A mental health
psychotherapist was integrated within the primary care
office by utilizing video technology. When patients
came to see their doctor and displayed a mild to
moderate mental health condition, they could see a
therapist in the same location on the same day. As a
follow-up, trained CHWs visited the patient at home or
over the phone, depending on preference, to conduct
motivational interviewing and connect the patient with
resources to sustain their positive health outcomes.

This is just one illustration of how reverse innovation
can improve care delivery.
Table 3. Drivers of Diffusion Models
Detroit
Innovation Model
Community
Need
Access to
Hub and spoke
mental health service delivery
services
model
Affordable
treatment
options

CHW workforce
model and telehealth product and
health information
model

Drivers of Diffusion

Complementarity to existing
HFHS medical infrastructure;
promise of effectiveness to reduce
transportation barriers; trialability
Low-cost and identification of
reimbursement mechanism for
both telehealth and CHWs
deployment; Regard for patient
feedback and satisfaction

Table 3 summarizes the core drivers that guided its
use of Dearing et al’s third and fourth phases to
achieve diffusion of a ‘low-high’ innovation in Detroit.

4.2 LGBTQ Peer Empowerment and Health
Navigation
GHI recently partnered with a Detroit-area
nonprofit organization serving young, homeless,
LGBTQ people. Nationally, LGBTQ identity among
youth correlates with a 2.2 times increased risk for
homelessness [20]. Young people in Detroit who
identify themselves as LGBTQ struggle with housing
insecurity, and nearly 40% are HIV positive. GHI’s
partnership seeks to innovatively reduce the rate of
HIV incidence and increase access to testing, preexposure prophylaxis (PrEP), and education. Because
of the correlation between homelessness and poor
health outcomes, GHI searched innovation databases
and among partners for approaches that factored in
employment and income in its search. Additionally,
because of the unique population being served, search
criteria included marginalized and vulnerable
demographic subgroups. The resultant search led to a
unique solution that addressed income insecurity (as a
proxy for homelessness) and limited access to HIV
education, testing, and therapy. A health workforce
innovation being used in a Southeast Asian LMIC was
identified for adaptation and testing.
The source partner in Southeast Asia shared many
of the Detroit partner’s context challenges: urban
density of the subject population (young, LGBTQ);
experiences of stigma and rejection; broad societal
recognition of LGBTQ identity; high-income
insecurity; and high rates of HIV incidence. Given the
similarities, conversations were initiated by GHI to
discern how the Southeast Asia-based partner had
recruited, hired, trained, deployed, and retained
housing-insecure LGBTQ young people in community
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health worker positions to help their peers navigate
their HIV care and prevention activities.
Two project initiatives have grown out of the
connection facilitated via GHI between the Detroit and
the Southeast Asia community organizations. First, a
Detroit pilot was initiated, modeled off the peer health
navigator effort, to adapt training and retention
modalities among Detroit young people to serve in a
similar role. Second, a community health worker
exchange was developed for peer navigators in both
settings to connect virtually in order to create a colocated “community of practice” exchange of cultural
lessons, best practices, strategies, and support for HIV
care.
In both examples, GHI started from a deep
understanding of local problems. However, the two
cases present slightly different approaches to
identifying solutions. For mental health, GHI utilized a
long-standing partner to identify the solution, while for
the sexual and reproductive health case study, GHI
scanned databases and external relationships to identify
a promising solution.
These case studies led GHI to conclude that
implementation challenges associated with diffusing
such innovations as well as opportunities for
identifying innovations that can support healthcare
need a generalizable framework in line with supporting
Dearing et al’s four phases. In other words, what is
needed is a source-agnostic, technology-facilitated
platform capable of capturing and diffusing
innovation-specific knowledge to facilitate diffusion.
In today’s complex market dynamic, organizations
are developing innovative products and services, often
supported by information technologies, to stay
effective and competitive in fulfilling their vision. To
create value, these innovations must be explored at an
ever-faster speed. Leading the innovation process using
enabling and adaptive leadership is important, along
with the administrative leadership to run the regular
business [21, 22]. HFHS, with all the global
communities it serves, has an extended healthcare
network. GHI facilitates the “adoption” by LMIC
communities of innovative public health practices
generated within the US, while simultaneously
“enabling” the evaluation and adaptation of ideas
generated within its global community network for
potential adoption in the US. To support low-high and
high-low innovation dissemination, GHI needs an
innovation fostering platform that helps support the
coordination of multiple stakeholders in the
exploration, learning, adaptation, and evaluation of
both forward and reverse innovations, as it designs
diffusion strategies to address global community needs.
The following section proposes the development of a
global health innovation platform (GHIP) to support

diffusion of innovations across a global community
network.

5. Discussion
5.1. GHIP Model for Platform Development
The GHIP platform captures the knowledge of all
public healthcare practices that are diffused to various
communities successfully, as well as those that are
successful in one community with a potential for
exploration elsewhere. It also captures community
efforts that make adaptations successful for any
number of reasons, as these can be helpful in future
decisions related to adoption and diffusion. The
platform has three underlying mechanisms to foster
innovation. The three mechanisms foster innovation by
supporting (1) information integration and knowledge
coordination; (2) multi-stakeholder engagement to
scout, share, and disseminate knowledge to foster
innovation; and (3) servitization and productization
agility to create products and processes that support
innovation. These three mechanisms are discussed
next.

Figure 2: The Innovation Fostering Activities of a
Global Health Platform

5.2 Information integration and knowledge
coordination
When knowledge within a firm is isolated within
the boundaries of a sub-unit, it hinders the capacity of
an organization to recombine it in the quest for
innovation [23]. Interdepartmental separation and lack
of co-ordination results in poor understanding and low
synchronization of the knowledge needed to develop
new products [24]. Integration across organizational
silos can help overcome barriers to the continuous
expansion of knowledge, and such knowledge
accumulation is needed to facilitate the generation of
novel ideas and create new knowledge [25]. Innovation
requires the creation of knowledge and the sharing of
this knowledge to mobilize action towards problem
solving [8], and the mechanism proposed supports such
a sharing of knowledge across organizational silos.
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Similarly, the importance of access to knowledge for
innovation is well recognized (e.g. [26, 27]). Access to
knowledge here refers to the availability of knowledge
from multiple sources to help workers within a firm
improve their potential to innovate [28]. Building
knowledge to support access requires the
documentation of various diffusion models,
contextualized by community characteristics.
GHI has both an opportunity and a capability to
create a knowledge repository of healthcare practices
that can be used for search and retrieval. This was
illustrated with the use of the hub and spoke model to
support mental health rehabilitation in the US.

5.3. Fostering innovation
stakeholder engagement

through

multi-

An innovative ecosystem within an organization
strives to improve links across different units, agents,
and stakeholders to support alignment of two different
mindsets or perspectives: an innovative mindset that is
non-linear in thinking and risk-taking, and a business
mindset that is methodical and somewhat risk-averse in
its calculation of return on investment. A platform can
act as a bridge between these two by collecting ideas,
openly and/or anonymously, for consideration as a way
to allow unbiased, non-linear thinking. It can then
publish selected ideas and the criteria used for their
support to convey a business case on risks, returns, and
value. Such a clear articulation of the thinking that
went into submission and selection can lead to
informal discussion and continual refinement over
time, thus bridging the gap between these two different
mindsets. More importantly, people over time can
engage in brainstorming ideas and their prioritization
using a broader view of how to support a culture of
innovation.
For example, those seeking grants to support public
health practice diffusion may need to adopt a business
mindset to articulate measurable value propositions,
while those responsible for diffusing the practice into a
global community need to embrace non-linear thinking
and some risk-taking. Bridging these two perspectives,
while a challenge, can also lead to opportunities over
time if prior knowledge can be used to help either
develop a new approach or evaluate the viability of an
existing approach.
The individual researchers and global community
practitioners can each act as consultants or observers in
the exploration and diffusion process. Enabled by the
platform, GHI can help bridge the differences in the
perspectives each one will bring.

5.4. Productization and servitization agility

Dynamic capabilities theory argues that agility is a
key for innovation [29]. This theory posits that
dynamic capabilities are important contributors to an
organization’s ability to change and adapt. Innovative
organizations that produce products need servitization
agility (the ability of a business to adapt to changing
conditions that demand services) and productization
agility (the ability to use innovation-to-product
architecture by creating products from services) [30].
While most product companies that want to be active
in providing services will design these products for
service, many service companies must convert their
practice knowledge into products.
Servitization for GHI may include modularizing
healthcare practices in components that can act as
training modules for care providers (e.g. nurses or
community health workers), mobile apps that can
provide step-by-step implementation of practice
knowledge, or products with embedded AI. An
illustration of the last example is a medical device that
draws blood and has an intelligent agent that poses
questions regarding the context before blood is drawn
or after for storage. The resulting knowledge
repositories can lead to opportunities for creating
“products” (servitization) that can have broader use
and potential commercialization.
GHI can be a vehicle for such servitization and has
already demonstrated it through its bootcamp program
used to provide standardized training discussed in
Table 2.
In summary, GHI acts as catalyst to foster public
healthcare practice diffusion by bridging the mindset of
those with both linear and non-linear thinking and
leverage the knowledge base in support of exploration
and evaluation.

6. Conclusion
Lack of confidence in the quality and effectiveness
of a practice that worked in a developing country and
its adaptability to the US context is a major challenge
in moving innovations freely across a global network.
GHI addresses this challenge by evaluating innovative
healthcare practices on clinical quality and
effectiveness. While this evaluation is value agnostic
with respect to the geographic, social, and cultural
settings from within which the innovation originates,
GHI has to pay particular attention to the contextual
factors that both the innovation source and the
recipient have in common. Using many elements GHI
used in the diffusion of public health practices across
the global network, the paper proposes a GHIP
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platform to support the identification of innovation
types for diffusing public health practices.
Using a taxonomy for the characterization and
searchability of these innovations, GHI can support
dialogue, positively influence mindsets, and support
both linear and non-linear thinking among multiple
stakeholders to support the wider sharing of practices
that have shown value. Believing that there is much
more that global communities share with one another
than separately define them, GHI offers GHIP as a
model of equity-building in innovation diffusion, as
well as a functional tool to identify opportunities for
servitization of diffusion models for faster deployment
in the future. We conclude by suggesting three future
research directions to facilitate global value cocreation, partnerships, and improved search to nurture
innovation flow.

6.1. Opportunities for collaborative value
creation
While the current GHI model creates value through
co-design of methods captured in its knowledge
repository by contextualizing these to the social
context, it sees potential to co-create value through
collaboration. As it solicits ideas from the local
community for public healthcare practices that can
address a key need, it can concurrently search the
knowledge base to identify practices that were diffused
effectively in communities at large with similar social,
economic, technical, and educational challenges. Such
practices can be shared with communities it serves
(e.g. Detroit) and let these communities identify their
potential as well as challenges. Such a process can be
reversed as well, with the global community
identifying a need and the US community sharing what
worked for them. This public-to-public collaboration
model can be enabled by GHI and fine-turned by the
various internal HFHS teams before pilot testing in the
community begins. This enables HFHS to focus on the
specific clinical or population health aspects of the
practice, while the larger community (public) can, in
collaboration with GHI, decide on its social relevance.

6.2. Partnership for Diffusion of Practice
GHI, using the GHIP platform, can start to build an
extensive repository of innovations over the course of
several years of research, training, and capacity
building activities around the world. While some of
these innovations can be broader in focus, GHI can
narrowly define some it can lead, based on the skillset
of its labor force, the leveragability of
multidisciplinary relationships with medical providers

and experts from across the health system, and a
careful examination of the most salient health
challenges in the area it serves. However, it may
choose to partner with other healthcare organizations
if a community decides the appropriateness of some
innovations outside its focus area.

6.3. Innovation Search Criteria
Both collaboration and partnerships can be
supported if the search criteria used to identify
innovations in the knowledge repository can be
expanded. At this time, the topics on which the search
can be conducted include: source of innovation (where
it is developed); income status of source (on some
metric such as GDP); population density; religious,
ethnic, racial, or demographic characteristic(s); and
type of innovation. Other types of information can be
added, such as who implemented the innovation;
characteristic(s) of the innovation recipient or
beneficiary; and contextual considerations of the
source that adopted the innovation (e.g. limited
transportation infrastructure, high access challenge,
severe uptick of a disease, etc.). By gathering such
data, innovation type search by communities can also
be supported with the influencers who played a role in
their implementation as well as any other value
propositions, all supporting the first two phases of
design for diffusion among global communities GHI
serves.
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